Item(by='reasonattlm', descendants=None, kids=None, score=None, time=1602698219, title=None, item_type='comment', url=None, parent=24779100, text='Dasatinib + quercetin has been shown in a clinical trial to remove senescent cells in humans in much the same way it does in mice [1].<p>High dose fisetin (i.e. take a whole bottle of the stuff at one go, not just a couple of pills) works about as well as dasatinib + quercetin in mice, but absent published results from the presently ongoing Mayo Clinic trial we&#x27;re all dubious that will translate to humans, given how widely these sorts of compounds have been consumed, tested, and assayed [2].<p>Ditto piperlongumine.<p>Beyond that, there are any number of biotech startups developing senolytic immunotherapies, small molecules, gene therapies, topical cosmetics, etc. [3]<p>[1]: <a href="https:&#x2F;&#x2F;doi.org&#x2F;10.1016&#x2F;j.ebiom.2019.08.069" rel="nofollow">https:&#x2F;&#x2F;doi.org&#x2F;10.1016&#x2F;j.ebiom.2019.08.069</a><p>[2]: <a href="https:&#x2F;&#x2F;brain.forever-healthy.org&#x2F;display&#x2F;EN&#x2F;Fisetin+Senolytic+Therapy" rel="nofollow">https:&#x2F;&#x2F;brain.forever-healthy.org&#x2F;display&#x2F;EN&#x2F;Fisetin+Senolyt...</a><p>[3]: <a href="http:&#x2F;&#x2F;agingbiotech.info&#x2F;companies&#x2F;" rel="nofollow">http:&#x2F;&#x2F;agingbiotech.info&#x2F;companies&#x2F;</a>')